Effect of Deutetrabenazine on Chorea Among Patients With Huntington DiseaseJane Kerr, Christina Vaughan, Jody Goldstein et al.|JAMA|2016Cited by 397
A randomized, double-blind, placebo-controlled trial of coenzyme Q10 in Huntington diseaseAndrew McGarry, Lauren Seeberger, Michael McDermott et al.|Neurology|2016Cited by 137
Safety and efficacy of pridopidine in patients with Huntington's disease (PRIDE-HD): a phase 2, randomised, placebo-controlled, multicentre, dose-ranging studyRalf Reilmann, Hope Heller, Andrew McGarry et al.|The Lancet Neurology|2018Cited by 108
Effect of Deutetrabenazine on Chorea Among Patients With Huntington Disease A Randomized Clinical TrialSamuel Frank, Richard Dubinsky, Claudia Testa et al.|Publisher|2016Cited by 44
Safety and Tolerability of SRX246, a Vasopressin 1a Antagonist, in Irritable Huntington’s Disease Patients—A Randomized Phase 2 Clinical TrialMichael Brownstein, Stephanie Lowenhaupt, Neal G. Simon et al.|Journal of Clinical Medicine|2020Cited by 32